Correction : Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies (Blood Cancer Journal, (2021), 11, 5, (94), 10.1038/s41408-021-00480-w)

Almenn færsla
dc.contributor.authorRögnvaldsson, Sæmundur
dc.contributor.authorLöve, Þorvarður Jón
dc.contributor.authorÞorsteinsdóttir, Sigrún
dc.contributor.authorReed, Elín Ruth
dc.contributor.authorÓskarsson, Jón Þórir
dc.contributor.authorPétursdóttir, Íris
dc.contributor.authorSigurðardóttir, Guðrún Ásta
dc.contributor.authorViðarsson, Brynjar
dc.contributor.authorÖnundarson, Páll Torfi
dc.contributor.authorAgnarsson, Bjarni Agnar
dc.contributor.authorSigurðardóttir, Margrét
dc.contributor.authorÞorsteinsdóttir, Ingunn
dc.contributor.authorÓlafsson, Ísleifur
dc.contributor.authorÞórðardóttir, Ásdís Rósa
dc.contributor.authorEyþórsson, Elías Sæbjörn
dc.contributor.authorJónsson, Ásbjörn
dc.contributor.authorBjörnsson, Andri Steinþór
dc.contributor.authorGunnarsson, Gunnar Þór
dc.contributor.authorPálsson, Runólfur
dc.contributor.authorIndriðason, Ólafur Skúli
dc.contributor.authorGíslason, Gauti Kjartan
dc.contributor.authorÓlafsson, Andri
dc.contributor.authorHákonardóttir, Guðlaug Katrín
dc.contributor.authorBrinkhuis, Manje
dc.contributor.authorHalldórsdóttir, Sara Lovísa
dc.contributor.authorÁsgeirsdóttir, Tinna Laufey
dc.contributor.authorSteingrímsdóttir, Hlíf
dc.contributor.authorDanielsen, Ragnar
dc.contributor.authorWessman, Inga Dröfn
dc.contributor.authorKampanis, Petros
dc.contributor.authorHultcrantz, Malin
dc.contributor.authorDurie, Brian G.M.
dc.contributor.authorHarding, Stephen
dc.contributor.authorLandgren, Ola
dc.contributor.authorKristinsson, Sigurður Yngvi
dc.contributor.departmentFaculty of Medicine
dc.contributor.departmentFaculty of Psychology
dc.contributor.departmentFaculty of Economics
dc.contributor.schoolEducation
dc.date.accessioned2025-11-20T09:12:46Z
dc.date.available2025-11-20T09:12:46Z
dc.date.issued2023-03-20
dc.descriptionPublisher Copyright: © The Author(s) 2023.en
dc.description.abstractIn this article the author name Malin Hultcrantz was incorrectly written as Malin Hulcrantz. The original article has been corrected.en
dc.format.extent394626
dc.format.extent39
dc.identifier.citationRögnvaldsson, S, Löve, Þ J, Þorsteinsdóttir, S, Reed, E R, Óskarsson, J Þ, Pétursdóttir, Í, Sigurðardóttir, G Á, Viðarsson, B, Önundarson, P T, Agnarsson, B A, Sigurðardóttir, M, Þorsteinsdóttir, I, Ólafsson, Í, Þórðardóttir, Á R, Eyþórsson, E S, Jónsson, Á, Björnsson, A S, Gunnarsson, G Þ, Pálsson, R, Indriðason, Ó S, Gíslason, G K, Ólafsson, A, Hákonardóttir, G K, Brinkhuis, M, Halldórsdóttir, S L, Ásgeirsdóttir, T L, Steingrímsdóttir, H, Danielsen, R, Wessman, I D, Kampanis, P, Hultcrantz, M, Durie, B G M, Harding, S, Landgren, O & Kristinsson, S Y 2023, 'Correction : Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies (Blood Cancer Journal, (2021), 11, 5, (94), 10.1038/s41408-021-00480-w)', Blood Cancer Journal, vol. 13, no. 1, 39, pp. 39. https://doi.org/10.1038/s41408-023-00814-wen
dc.identifier.doi10.1038/s41408-023-00814-w
dc.identifier.issn2044-5385
dc.identifier.other114020454
dc.identifier.other5411136a-8801-40e7-8707-c66e0669084a
dc.identifier.other85150531593
dc.identifier.other36935437
dc.identifier.otherunpaywall: 10.1038/s41408-023-00814-w
dc.identifier.urihttps://hdl.handle.net/20.500.11815/7156
dc.language.isoen
dc.relation.ispartofseriesBlood Cancer Journal; 13(1)en
dc.relation.urlhttps://www.scopus.com/pages/publications/85150531593en
dc.rightsinfo:eu-repo/semantics/openAccessen
dc.subjectHematologyen
dc.subjectOncologyen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.titleCorrection : Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies (Blood Cancer Journal, (2021), 11, 5, (94), 10.1038/s41408-021-00480-w)en
dc.type/dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/commenten

Skrár

Original bundle

Niðurstöður 1 - 1 af 1
Nafn:
s41408_023_00814_w.pdf
Stærð:
385.38 KB
Snið:
Adobe Portable Document Format
Hlaða niður

Undirflokkur

Háskóli Íslands

Öll gögn í Opnum vísindum eru vernduð af ákvæðum höfundalaga og með öllum réttindum áskildum, nema annað sé tekið fram.